The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Cognitive decline in Parkinson disease
Open accessAbstract
Dementia is a frequent problem encountered in advanced stages of Parkinson disease (PD). In recent years, research has focused on the pre-dementia stages of cognitive impairment in PD, including mild cognitive impairment (MCI). Several longitudinal studies have shown that MCI is a harbinger of dementia in PD, although the course is variable, and stabilization of cognition - or even reversal to normal cognition - is not uncommon. In addition to limbic and cortical spread of Lewy pathology, several other mechanisms are likely to contribute to cognitive decline in PD, and a variety of biomarker studies, some using novel structural and functional imaging techniques, have documented in vivo brain changes associated with cognitive impairment. The evidence consistently suggests that low cerebrospinal fluid levels of amyloid-β 42, a marker of comorbid Alzheimer disease (AD), predict future cognitive decline and dementia in PD. Emerging genetic evidence indicates that in addition to the APOE*ε4 allele (an established risk factor for AD), GBA mutations and SCNA mutations and triplications are associated with cognitive decline in PD, whereas the findings are mixed for MAPT polymorphisms. Cognitive enhancing medications have some effect in PD dementia, but no convincing evidence that progression from MCI to dementia can be delayed or prevented is available, although cognitive training has shown promising results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover there are several candidate genetic risk factors that overlap for AD and PD, most notably APOE and MAPT [127].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationLitvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609
Self-citationThe Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., ADENA, M. A., Halliday, G. M., & Morris, J. G. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,346
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Prevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403
Self-citationMultimodal classification of Alzheimer's disease and mild cognitive impairment
Zhang, D., Wang, Y., Zhou, L., Yuan, H., & Shen, D. G. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.008 · Cited by 1,340
Cited by
Sorted by citations
Items 401–500 of 1,000
Santo, G. D., de Veras, B. O., Rico, E. P., Magro, J. D., Agostini, J. F., Filho, L. D. V., Calisto, J. F. F., Mocelin, R., Fonseca, V. D. S., & Wanderley, A. G. (2020) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2020.108953 · Cited by 17
Ophey, A., Krohm, F., Kalbe, E., Greuel, A., Drzezga, A. E., Tittgemeyer, M., Timmermann, L., Jessen, F., Eggers, C., & Maier, F. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05734-w · Cited by 16
Fan, Y., Han, J., Zhao, L., Wu, C., Wu, P., Huang, Z., Hao, X., Ji, Y., Chen, D., & Zhu, M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.745438 · Cited by 16
Parkinson's disease and Covid-19: The effect and use of telemedicine
Podlewska, A. M., & van Wamelen, D. J. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.04.002 · Cited by 16
Bianchini, E., Caliò, B., Alborghetti, M., Rinaldi, D., Hansen, C., Vuillerme, N., Maetzler, W., & Pontieri, F. E. (2022) · Sensors · doi:10.3390/s23010214 · Cited by 16
Meng, L., Wang, D., Shi, Y., Li, Z., Zhang, J., Lu, H., Zhu, X., & Ming, D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1252610 · Cited by 16
Prospective memory functioning in individuals with Parkinson’s disease: a systematic review
da Costa, A. L. C., Caltagirone, C., & Carlesimo, G. A. (2017) · The Clinical Neuropsychologist · doi:10.1080/13854046.2017.1407457 · Cited by 16
Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson’s Disease
Yang, X. Q., Lauzon, B., Seergobin, K. N., & MacDonald, P. A. (2018) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00642 · Cited by 16
Madireddy, S., & Madireddy, S. (2019) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001026 · Cited by 16
Detecting the Cognitive Prodrome of Dementia in Parkinson’s Disease
Roy, J. D., Postuma, R. B., Brillon-Corbeil, M., Montplaisir, J. Y., Marchand, D. G., Escudier, F., Panisset, M., Chouinard, S., & Gagnon, J. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191857 · Cited by 16
Kochunov, P. V., Ryan, M. C., Yang, Q., Hatch, K. S., Zhu, A. H., Thomopoulos, S. I., Jahanshad, N., Schmaal, L., Thompson, P. M., Chen, S., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102574 · Cited by 16
Urso, D., Leta, V., Batzu, L., Yousaf, T., Farrell, C. M., van Wamelen, D. J., & Chaudhuri, К. R. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10730-3 · Cited by 16
Stewart, S. A., Pimer, L., Fisk, J. D., Rusak, B., Leslie, R. A., Eskes, G. A., Schoffer, K. L., McKelvey, J. R., Rolheiser, T. M., Khan, M. N., et al. (2021) · Clinical EEG and Neuroscience · doi:10.1177/15500594211058263 · Cited by 16
Maraki, M. I., Hatzimanolis, A., Mourtzi, N., Stefanis, L., Yannakoulia, M., Kosmidis, M. H., Dardiotis, E., Hadjigeorgiou, G. M., Sakka, P., Ramı́rez, A., et al. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.739571 · Cited by 16
Abasi, A., Hoseinabadi, R., Raji, P., Friedman, J. H., & Hadian, M. R. (2022) · Parkinson s Disease · doi:10.1155/2022/6913691 · Cited by 16
van Balkom, T. D., van den Heuvel, O. A., Berendse, H. W., van der Werf, Y. D., & Vriend, C. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102952 · Cited by 14
How Human Single-Neuron Recordings Can Help Us Understand Cognition: Insights from Memory Studies
Kubska, Z. R., & Kamiński, J. (2021) · Brain Sciences · doi:10.3390/brainsci11040443 · Cited by 15
Sadık, E. Ş., Saraoğlu, H. M., Kabay, S. C., Tosun, M., Keskinkılıç, C., & Akdağ, G. (2021) · Signal Image and Video Processing · doi:10.1007/s11760-021-01992-5 · Cited by 15
Counsell, C. E., Giuntoli, C., Khan, Q. I., Maple‐Grødem, J., & Macleod, A. D. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11058-2 · Cited by 15
Wal, P., Dwivedi, J., Wal, A., Vig, H., & Singh, Y. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00425-5 · Cited by 15
Palmas, M. F., Etzi, M., Pisanu, A., Camoglio, C., Sagheddu, C., Santoni, M., Manchinu, M. F., Pala, M., Fusco, G., Simone, A. D., et al. (2022) · Cells · doi:10.3390/cells11172628 · Cited by 15
Wang, F., Lai, Y., Pan, Y., Li, H., Liu, Q., & Sun, B. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00403-x · Cited by 15
Zhang, P., Rong, S., He, C., Li, Y., Li, X., Chen, Z., Nie, K., Wang, L., Wang, L., & Zhang, Y. (2023) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-22-582 · Cited by 15
Bernardi, S., Gemignani, F., & Marchese, M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106258 · Cited by 15
Gorji, A., & Jouzdani, A. F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304355 · Cited by 19
Takamatsu, Y., Fujita, M., Ho, G. J., Wada, R., Sugama, S., Takenouchi, T., Waragai, M., Masliah, E., & Hashimoto, M. (2018) · Parkinson s Disease · doi:10.1155/2018/5789424 · Cited by 15
Sampedro, F., Marín‐Lahoz, J., Martínez‐Horta, S., Pagonabarraga, J., & Kulisevsky, J. (2019) · Brain Imaging and Behavior · doi:10.1007/s11682-018-0022-y · Cited by 15
Guo, Y., Zhang, L., Zhang, J., Du, C., Lv, S.-X., Wang, T., Wang, H.-S., Xie, W., & Liu, J. (2019) · PubMed · doi:10.1080/01616412.2019.1596055 · Cited by 15
Shi, M., Ma, C., Chen, F., Zhou, X., Li, X., Tang, C.-X., Zhang, L., & Gao, D. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.297091 · Cited by 15
Diagnosing Parkinson’s Disease Using Multimodal Physiological Signals
Guo, G., Wang, S., Shuaibin, W., Zhou, Z., Pei, G., & Yan, T. (2021) · Communications in computer and information science · doi:10.1007/978-981-16-1288-6_9 · Cited by 15
Pinizzotto, C. C., Patwardhan, A., Aldarondo, D., & Kritzer, M. F. (2022) · Hormones and Behavior · doi:10.1016/j.yhbeh.2022.105206 · Cited by 15
Bi, Y., Huang, N., Xu, D., Wu, S., Meng, Q., Chen, H.-Q., Li, X., & Chen, R. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.135808 · Cited by 14
Jiao, H., Guo, Z., Sun, J., Wang, K., & Yang, J. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1510418 · Cited by 15
Torres-Yaghi, Y., Carwin, A., Carolan, J., Nakano, S., Amjad, F., & Pagan, F. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s324145 · Cited by 14
Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis
Abler, V., Brain, C., Ballard, C. G., Berrio, A., Coate, B., & Espay, A. J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.919778 · Cited by 14
Self-citationWang, Z., Liu, M., Sun, Z., Zhang, X., Zhang, M., Xiong, K., & Zhou, F. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.1027044 · Cited by 14
Cao, R., Chen, C., Wen, J., Zhao, W., Zhang, C., Yuan, L., Yuan, L., Wu, C., Shan, L., Xi, M., et al. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106906 · Cited by 14
Application and progress of advanced eye movement examinations in cognitive impairment
Leng, Q., Deng, B., & Ju, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1377406 · Cited by 14
Yang, C., Wei, C., Ughi, F., Chang, J.-Y., Pijanowska, D. G., & Lai, C. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.136006 · Cited by 14
Oh, Y., Kim, J., Lyoo, C. H., Park, G., & Kim, H. (2024) · Neurology · doi:10.1212/wnl.0000000000209498 · Cited by 16
Assessment tools for cognitive performance in Parkinson’s disease and its genetic contributors
Cao, L., Kong, W. L., Chan, P., Zhang, W., Morris, M. J., & Huang, Y. M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1413187 · Cited by 14
Guan, Z. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70069 · Cited by 14
Timely Detection of Mild Cognitive Impairment in Italy: An Expert Opinion
Bianchetti, A., Ferrara, N., Padovani, A., Scarpini, E. A., Trabucchi, M., & Maggi, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181253 · Cited by 15
Status and future directions of clinical trials in Parkinson's disease
Söderbom, G. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.009 · Cited by 14
Oosterveld, L. P., Kuiper, T. I., Majbour, N. K., Verberk, I. M. W., van Dijk, K. D., Twisk, J. W. R., El‐Agnaf, O. M. A., Teunissen, C. E., Weinstein, H. C., Klein, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228519 · Cited by 15
Mihaescu, A. S., Kim, J., Masellis, M., Graff‐Guerrero, A., Cho, S. S., Christopher, L., Valli, M., Díez‐Cirarda, M., Koshimori, Y., & Strafella, A. P. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24760 · Cited by 14
Andersson, S., Josefsson, M., Jonasson, L. S., & Rieckmann, A. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.729755 · Cited by 14
Genes and Nonmotor Symptoms in Parkinson's Disease
Lim, E., & Tan, E. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.029 · Cited by 14
Alzheimer’s Disease and Parkinson Dementia Distinguished by Cognitive Marker
Козлова, И. А., Parra, M. A., Titova, N., Гантман, М. В., & Sala, S. D. (2020) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acz082 · Cited by 14
Altered microstructural properties of superficial white matter in patients with Parkinson’s disease
Zhang, Y., Huang, B., Chen, Q., Wang, L., Zhang, L., Nie, K., Huang, Q., & Huang, R. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00522-8 · Cited by 13
Can Berberine Serve as a New Therapy for Parkinson’s Disease?
Dadgostar, E., Moghanlou, M., Parvaresh, M., Mohammadi, S., Khandan, M., Aschner, M., Mirzaei, H., & Tamtaji, O. R. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00526-2 · Cited by 13
Liu, H.-H., Wang, R., Cheng, S.-J., Liao, K., Zhou, J., & Yang, Y. (2022) · Geriatric Nursing · doi:10.1016/j.gerinurse.2022.08.004 · Cited by 13
Rinaldi, D., Alborghetti, M., Bianchini, E., Sforza, M., Galli, S., & Pontieri, F. E. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220905102144 · Cited by 13
Santos‐García, D., Fonticoba, T. D. D., Bartolomé, C. C., Painceiras, M. J. F., González, J. M. P., Miró, C. M., Jesús, S., Aguilar, M., Pástor, P., Planellás, L., et al. (2023) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.0186 · Cited by 13
The role of orexin in Parkinson's disease
Braun, A., Manavis, J., Yamanaka, A., Ootsuka, Y., Blumbergs, P. C., & Bobrovskaya, L. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25322 · Cited by 14
Beheshti, I., & Ko, J. H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1375395 · Cited by 17
Kinematic and Kinetic Gait Features Associated With Mild Cognitive Impairment in Parkinson’s Disease
Russo, M., Amboni, M., Volzone, A., Cuoco, S., Camicioli, R. M., Filippo, F. D., Barone, P., Romano, M., Amato, F., & Ricciardi, C. (2024) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2024.3431234 · Cited by 13
A worldwide study of subcortical shape as a marker for clinical staging in Parkinson’s disease
Laansma, M. A., Zhao, Y., van Heese, E. M., Bright, J. K., Owens‐Walton, C., Al–Bachari, S., Anderson, T., Assogna, F., van Balkom, T. D., Berendse, H. W., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00825-9 · Cited by 13
Self-citationAcar, N., Parlak, H., Özkan, A., Soylu, H., Avcı, S., Üstünel, İ., Izgut-Uysal, V. N., & Ağar, A. (2018) · Tissue and Cell · doi:10.1016/j.tice.2018.12.002 · Cited by 13
Dana, A., Shams, A., علافان, ن., & Bahrami, A. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05184-4 · Cited by 13
Stuckenschneider, T., Abeln, V., Foitschik, T., Abel, T., Polidori, M. C., & Strüder, H. K. (2021) · Brain and Behavior · doi:10.1002/brb3.2352 · Cited by 13
Clements, R. T., Fuller, L. E., Kraemer, K. R., Radomski, S. A., Hunter-Chang, S., Hall, W. C., Kalantar, A. A., & Kraemer, B. R. (2022) · eNeuro · doi:10.1523/eneuro.0327-21.2022 · Cited by 13
Cognition, function and awareness of disease impact in early Parkinson’s and Huntington’s disease
Júlio, F., Ribeiro, M. J., Morgadinho, A., Sousa, M., van Asselen, M., Simões, M. R., Castelo-Branco, M. S., & Januário, C. (2020) · Disability and Rehabilitation · doi:10.1080/09638288.2020.1783001 · Cited by 16
Huang, M., Yu, H., Cai, X., Zhang, Y., Pu, W., & Gao, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-41569-5 · Cited by 13
Dyskinesia and FAB score predict future falling in Parkinson's disease
Lindholm, B., Eek, F., Skogar, Ö., & Hansson, E. E. (2019) · Acta Neurologica Scandinavica · doi:10.1111/ane.13084 · Cited by 13
Li, X., Xiong, Y., Liu, S., Zhou, R., Hu, Z., Tong, Y., He, L., Niu, Z., Ma, Y., & Guo, H. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00668 · Cited by 13
Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics
Butala, A., Shepard, M. D., & Pontone, G. M. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00007-1 · Cited by 13
Gonçalves, A. M. R., Pereira-Santos, A. R., Esteves, A. R., Cardoso, S. M., & Empadinhas, N. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7997 · Cited by 13
Conner, M. R., Jang, D., Anderson, B. J., & Kritzer, M. F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00942 · Cited by 14
Szwedo, A. A., Pedersen, C. C., Ushakova, A., Forsgren, L., Tysnes, O., Counsell, C. E., Alves, G. W., Lange, J., Macleod, A. D., & Maple‐Grødem, J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.620585 · Cited by 13
Cheng, F., Fransson, L., & Mani, K. (2021) · Glycobiology · doi:10.1093/glycob/cwab126 · Cited by 13
Mortality of Parkinson’s disease in Italy from 1980 to 2015
Ulivelli, M., Bezzini, D., Kundisova, L., Grazi, I., Battaglia, M. A., Nante, N., & Rossi, S. (2022) · Neurological Sciences · doi:10.1007/s10072-021-05854-3 · Cited by 13
Mohiuddin, M., Asghar, T., Hameed, H., Din, A. M., Siddique, A., Younas, S., Din, M. M. U., & Ara, R. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04632-z · Cited by 13
Koh, M. R. E., Chua, C. Y., Ng, S. Y., Chia, N. S. Y., Saffari, S. E., Chen, R. Y.-Y., Choi, X., Heng, D. L., Neo, S., Tay, K. Y., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.998103 · Cited by 12
Micro/nanoparticle-enabled ultrasound therapy of brain diseases
Qiu, L., Zhu, Z., Liang, J., Qiao, X., Xu, H., Xiang, H., Ding, H., & Chen, Y. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215531 · Cited by 12
Parkinson's Disease and Driving Fitness: A Systematic Review of the Existing Guidelines
Stamatelos, P., Economou, A., Yannis, G., Stefanis, L., & Papageorgiou, S. G. (2023) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13942 · Cited by 12
Online cognitive testing in Parkinson’s disease: advantages and challenges
Binoy, S., Algon, A. L., Adiva, Y. B., Montaser‐Kouhsari, L., & Saban, W. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1363513 · Cited by 12
Bosch‐Barceló, P., Climent‐Sanz, C., Martínez-Navarro, O., Masbernat, M. A., Pakarinen, A., Ghosh, P. K., & Fernández‐Lago, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307304 · Cited by 15
Yan, Y., Xu, Y., Wang, X., Wang, Y., Huang, C., Lin, R., Chen, M., Lin, M., & Li, H. (2024) · Geriatric Nursing · doi:10.1016/j.gerinurse.2024.08.028 · Cited by 12
Molecular Imaging of Dementia With Lewy Bodies
Cousins, O., Yousaf, T., Wilson, H., Pagano, G., & Politis, M. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.10.007 · Cited by 12
Self-citationChen, Y., Chen, H.-L., Lu, C.-H., Lee, C.-Y., Chou, K., Chen, M., Yu, C.-C., Lai, Y., Chiang, P., & Lin, W. (2021) · Scientific Reports · doi:10.1038/s41598-020-79403-x · Cited by 12
Pedersen, H. E., Sandvik, C. H., Subhi, Y., Grauslund, J., & Pedersen, F. N. (2021) · Ophthalmology Retina · doi:10.1016/j.oret.2021.07.002 · Cited by 12
Dysfunctional Brain Dynamics of Parkinson's Disease and the Effect of Acute Deep Brain Stimulation
Li, Z., Ren, G., Liu, C., Wang, Q., Liang, K., Han, C., Qiao, H., Zhang, J., Wang, Q., & Meng, F. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.697909 · Cited by 13
Sheng, Z.-H., Ma, L., Liu, J.-Y., Ou, Y., Zhao, B. T., Ma, Y., & Tan, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1061096 · Cited by 12
Wang, Y., Liu, J., Hui, Y., Wu, Z., Wang, L., Xiang, W., Bai, Y., Zhang, Q., & Li, L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1124819 · Cited by 13
Latella, D., Maresca, G., Formica, C., Sorbera, C., Bringandì, A., Lorenzo, G. D., Quartarone, A., & Marino, S. (2023) · Brain Sciences · doi:10.3390/brainsci13030499 · Cited by 12
Ogura, M., Kikuchi, H., Shakespear, N., Suzuki, T., Yamaki, J., Homma, Y., Oshima, Y., & Homma, Y. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.008 · Cited by 12
Suicide and Lewy body dementia: Report of a Lewy body dementia association working group
Armstrong, M. J., Sullivan, J. L., Amodeo, K., Lunde, A. M., Tsuang, D. W., Reger, M. A., Conwell, Y., Ritter, A. R., Bang, J., Onyike, C. U., et al. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5462 · Cited by 14
Zhai, Y., Wang, Q., Zhu, Z., Zheng, W., Ma, S., Hao, Y., Yang, L., & Cheng, G. (2021) · Biomedical Materials · doi:10.1088/1748-605x/ac4089 · Cited by 12
Aarsland, D., Rajkumar, A. P., & Hye, A. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315821 · Cited by 12
Self-citationTang, Y., Yang, H., Chen, X., Zhang, Z., Yao, X., Yin, X., & Guo, Z. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.15.472735 · Cited by 12
Diotaiuti, P., Marotta, G., Vitiello, S., Siena, F. D., Palombo, M., Langiano, E., Ferrara, M., & Mancone, S. (2025) · Brain Sciences · doi:10.3390/brainsci15070720 · Cited by 11
Ahmed, S., Pasam, T., & Afreen, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010486 · Cited by 12
Yi, G., Wang, Y., Wang, L., Chu, C., Wang, J., Shen, X. Y., Han, X., Li, Z., Bai, L., Li, Z., et al. (2023) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2023.3243035 · Cited by 11
Xie, H., Yang, Y., Sun, Q., Li, Z.-Y., Ni, M.-H., Chen, Z., Li, S., Dai, P., Cui, Y., Cao, X., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1289934 · Cited by 11
Repici, A., Capra, A. P., Hasan, A., Bulzomì, M., Campolo, M., Paterniti, I., Esposito, E., & Ardizzone, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084337 · Cited by 11
Hou, C., Yang, F., Li, S., Ma, H.-Y., Li, F.-X., Zhang, W., & He, W. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-23-1778 · Cited by 11
Neuroanatomical Signature of the Transition from Normal Cognition to MCI in Parkinson's Disease
Beheshti, I., Perron, J., & Ko, J. H. (2024) · Aging and Disease · doi:10.14336/ad.2024.0323 · Cited by 11
Houvenaghel, J., Meyer, M., Schmitt, E., Arifi, A., Benchetrit, E., Bichon, A., Cau, C., Lavigne, L., Mercier, E. L., Czernecki, V., et al. (2024) · Revue Neurologique · doi:10.1016/j.neurol.2024.06.008 · Cited by 11
Cao, B., Zhou, R., Chen, H.-W., Liang, Y., Liu, K., Fan, W.-D., Huang, R.-D., Huang, Y., Zhong, Q., & Wu, X. (2024) · The Gerontologist · doi:10.1093/geront/gnae139 · Cited by 11
Metadata
- Authors
- Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C.
- Affiliations
- King's College London (GB)
- Corresponding author
- Aarsland, Dag
- Venue
- Nature Reviews Neurology
- Published
- 2017-03-03
- Volume
- 13
- Issue
- 4
- Pages
- 217-231
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC5643027
- OpenAlex
- W2593272776
- Cited by
- 1,027
- References
- 216
- Citations by year
- 2026: 102 · 2025: 99 · 2024: 138 · 2023: 104 · 2022: 105 · 2021: 171 · 2020: 116 · 2019: 89 · 2018: 68 · 2017: 33
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- South London and Maudsley NHS Foundation Trust
- National Institute for Health and Care Research
- King's College London
- Institute of Psychiatry, Psychology and Neuroscience, King’s College London
- National Institute of Neurological Disorders and Stroke (P50NS053488)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Parkinson's disease, cognitive decline, Parkinson's disease dementia, mild cognitive impairment, cerebrospinal fluid biomarkers, amyloid-beta 42, Lewy body pathology, APOE ε4, GBA mutations, cognitive training, nootropic drugs
- MeSH terms
- Dementia, Humans, Parkinson Disease, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
